Rezolute (RZLT) Assets (2011 - 2026)
Rezolute (RZLT) posted Assets of $125.5 million for Q1 2026, down 9.5% sequentially from $138.6 million in Q4 2025, and up 32.43% YoY from $94.7 million in Q1 2025.
Rezolute (RZLT) Assets (2011 - 2026) Analysis & Trends
Rezolute has reported Assets for 16 years, with the latest figure at $125.5 million in Q1 2026.
- Quarterly Assets rose 32.43% year-over-year to $125.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.5 million (up 32.43% YoY) and the FY2025 annual result came in at $175.5 million, up 32.21% from the prior year.
- Assets eased to $125.5 million in Q1 2026 per RZLT's latest filing, from $138.6 million in the prior quarter.
- Over five years, Assets peaked at $175.5 million in Q2 2025 and troughed at $69.6 million in Q1 2022.
- A 5-year average of $126.5 million and a median of $125.5 million in 2026 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets soared 302.45% in 2022, then slumped 34.62% in 2024.
- Over 5 years, Assets stood at $150.2 million in 2022, then plunged by 31.99% to $102.1 million in 2023, then climbed by 9.65% to $112.0 million in 2024, then gained by 23.77% to $138.6 million in 2025, then dropped by 9.5% to $125.5 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $125.5 million, $138.6 million, and $158.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 125.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.46 Mn |
| Dec 31, 2025 | 138.63 Mn |
| Sep 30, 2025 | 158.66 Mn |
| Jun 30, 2025 | 175.49 Mn |
| Mar 31, 2025 | 94.74 Mn |
| Dec 31, 2024 | 112.01 Mn |
| Sep 30, 2024 | 123.41 Mn |
| Jun 30, 2024 | 132.74 Mn |
| Mar 31, 2024 | 87.74 Mn |
| Dec 31, 2023 | 102.15 Mn |
| Sep 30, 2023 | 113.00 Mn |
| Jun 30, 2023 | 123.72 Mn |
| Mar 31, 2023 | 134.21 Mn |
| Dec 31, 2022 | 150.21 Mn |
| Sep 30, 2022 | 155.99 Mn |
| Jun 30, 2022 | 152.42 Mn |
| Mar 31, 2022 | 69.57 Mn |
| Dec 31, 2021 | 83.41 Mn |
| Sep 30, 2021 | 38.76 Mn |
| Jun 30, 2021 | 42.61 Mn |